COVID-19 vaccine safety report (1 December 2022)

1 December 2022 - To 27 November 2022, the TGA has received 709 reports which have been assessed as likely to ...

Read more →

COVID-19 vaccine safety report (17 November 2022)

17 November 2022 - To 13 November 2022, the TGA has received 706 reports which have been assessed as likely to ...

Read more →

COVID-19 vaccine safety report (3 November 2022)

3 November 2022 - To 30 October 2022, the TGA has received 704 reports which have been assessed as likely to ...

Read more →

CHMP issues opinion related to review of medicines within the Janus kinase inhibitor class

11 November 2022 - AbbVie announced today the EMA's CHMP has adopted an opinion following a nine month review of the ...

Read more →

EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders

28 October 2022 - EMA’s safety committee (PRAC) has recommended measures to minimise the risk of serious side effects associated ...

Read more →

COVID-19 vaccine safety report (20 October 2022)

20 October 2022 - To 16 October 2022, the TGA has received 705 reports which have been assessed as likely to ...

Read more →

COVID-19 vaccine safety report (6 October 2022)

6 October 2022 - To 2 October 2022, the TGA has received 703 reports which have been assessed as likely to ...

Read more →

COVID-19 vaccine safety report (23 September 2022)

23 September 2022 - To 18 September 2022, the TGA has received 712 reports which have been assessed as likely to ...

Read more →

Independent review of paracetamol overdose

14 September 2022 - The TGA has published an independent expert report examining the incidence of serious injury and death ...

Read more →

COVID-19 vaccine safety report (8 August 2022)

8 September 2022 - To 4 September 2022, the TGA has received 699 reports which have been assessed as likely to ...

Read more →

COVID-19 vaccine safety report (25 August 2022)

25 August 2022 - To 21 August 2022, the TGA has received 674 reports which have been assessed as likely to ...

Read more →

COVID-19 vaccine safety report (11 August 2022)

11 August 2022 - To 7 August 2022, the TGA has received 665 reports which have been assessed as likely to ...

Read more →

COVID-19 vaccine safety report (28 July 2022)

29 July 2022 - To 24 July 2022, the TGA has received 615 reports which have been assessed as likely to ...

Read more →

EMA recommends restricting use of cancer medicine Rubraca

22 July 2022 - EMA’s human medicines committee, CHMP, has recommended that Rubraca (rucaparib camsylate) should no longer be used ...

Read more →

COVID-19 vaccine safety report (14 July 2022)

14 July 2022 - To 10 July 2022, the TGA has received 609 reports which have been assessed as likely to ...

Read more →